Raymond James Downgrades Profound Medical Corp. (PROF) to Outperform, 'we don’t expect big things from PROF’s early ramp in 1H25'
Tweet Send to a Friend
Raymond James analyst Michael Freeman downgraded Profound Medical Corp. (NASDAQ: PROF) from Strong Buy to Outperform with a price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
